Pilot Study of Docetaxel & Bevacizumab +/- Trastuzumab in First-Line Treatment of Patients With Metastatic Breast Cancer
Clinical trial NCT00364611 · COMPLETED
Trial details
- NCT number
- NCT00364611
- Sponsor
- Sanofi
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2006-08-01
- Primary completion
- 2011-06-01
- Enrollment
- 73
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.